An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

609

Participants

Timeline

Start Date

March 9, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Acne Vulgaris
Interventions
DRUG

CB-03-01 cream, 1%

Cortexolone 17α-propionate (USAN/INN: clascoterone) is a steroidal antiandrogen that is being developed as a 1% cream for the topical treatment of acne vulgaris.

Trial Locations (74)

1407

3520, Sofia

Site 3524, Sofia

1431

Site 3519, Sofia

1618

Site 3526, Sofia

4000

Site 3521, Plovdiv

8137

Site 8137, Belgrade

9010

Site 3522, Varna

9913

Site 9913, Tbilisi

10075

Sadick Research Group, LLC, New York

10155

Skin Specialty Dermatology, New York

11050

Site 8138, Belgrade

11790

DermResearch Center of New York, Inc., Stony Brook

17033

The Pennsylvania State University and the Milton S. Hershey Medical Center, Hershey

21000

Site 8136, Novi Sad

21030

Maryland Laser Skin and Vein Institute, Hunt Valley

23507

Clinical Research Associates of Tidewater, Inc., Norfolk

29607

Greenville Dermatology, LLC, Greenville

30263

MedaPhase, Inc., Newnan

33162

Tory Sullivan, M.D., P.A., North Miami Beach

33437

Study Protocol, Inc., Boynton Beach

33609

MOORE Clinical Research, Inc., Tampa

33709

Meridien Research, St. Petersburg

33781

Belleair Research Center, Pinellas Park

37130

International Clinical Research - Tennessee LLC, Murfreesboro

37215

Tennessee Clinical Research Center, Nashville

46032

Shideler Clinical Research Center, Carmel

46168

The Indiana Clinical Trials Center, Plainfield

48202

Henry Ford Health System, Detroit

49000

Site 3802, Dnipro

60005

Arlington Dermatology, Arlington Heights

61002

Site 3808, Kharkiv

61038

Site 3804, Kharkiv

64506

MediSearch Clinical Trials, Saint Joseph

66215

Kansas City Dermatology, PA, Overland Park

69063

Site 3809, Zaporizhzhya

72205

Gary M. Petrus, MD PA, Little Rock

72916

Johnson Dermatology, Fort Smith

77030

The University of Texas Health Science Center at Houston, Houston

78218

Texas Dermatology and Laser Specialists, San Antonio

78229

Progressive Clinical Research, PA, San Antonio

78660

Austin Institute for Clinical Research, Inc., Pflugerville

78746

Westlake Dermatology Clinical Research Center, Austin

80220

Horizons Clinical Research Center, LLC, Denver

90404

Clinical Science Institute, Santa Monica

92123

Rady Childrens Hospital, Pediatric and Adolescent Dermatology, San Diego

92701

Southern California Dermatology, Santa Ana

92780

Memorial Research Medical Clinic dba / Orange County Research Center, Tustin

95819

Center for Dermatology and Laser Surgery, Sacramento

97210

Oregon Dermatology and Research Center, Portland

98101

Dermatology Associates, Seattle

99202

Premier Clinical Research, Spokane

700381

Site 4037, Iași

02919

Clinical Partners, LLC, Johnston

02886

Omega Medical Research, Warwick

0114

Site 9912, Tbilisi

0159

Site 9911, Tbilisi

Unknown

Site 4814, Bialystok

4819, Bydgoszcz

Site 4822, Częstochowa

Site 4811, Dąbrówka

4815, Katowice

Site 4821, Krakow

Site 4820, Lodz

Site 4823, Osielsko

Site 4813, Szczecin

Site 4818, Warsaw

Site 4812, Wroclaw

Site 4028, Târgovişte

Site 4035, Bucharest

Site 4030, Sibiu

020125

Site 4033, Sector 2

Site 4034, Sector 2

030303

Site 4031, Sector 3

062272

Site 4029, Sector 6

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cassiopea SpA

INDUSTRY